EDWIN SANTOS: Open Payments
NPI 1689652281 · CAMPTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 42 payments from 13 companies in 2025. Trend: 2023 $492 · 2024 $534 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $240 |
| AstraZeneca Pharmaceuticals LP | 4 | $155 |
| GlaxoSmithKline, LLC. | 6 | $110 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Lilly USA, LLC | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Amgen Inc. | 1 | $21 |
| KYOWA KIRIN, INC. | 1 | $18 |
Products named: CAPLYTA, AIRSUPRA, TRELEGY ELLIPTA, GEMTESA, REXULTI, XIFAXAN, MOUNJARO, JARDIANCE.
Industry payments across KY — which companies pay providers there.
